Objective We aimed to evaluate all-cause and cause-specific mortality in patients with
systemic lupus erythematosus (SLE) and neuropsychiatric (NP) symptoms in the …

OBJECTIVE: Magnetic resonance imaging (MRI) often demonstrates brain lesions in
neuropsychiatric systemic lupus erythematosus (NPSLE). The present study compared …

The objective of this study was to examine mortality rates related to cerebrovascular disease
in systemic lupus erythematosus (SLE) compared to the general population. Our sample …

Objective To determine the frequency, characteristics, and outcomes of cerebrovascular
events (Cer VE s), as well as clinical and autoantibody associations in a multiethnic/racial …

Background and Purpose—To determine factors associated with ischemic stroke and stroke
severity in patients with systemic lupus erythematosus. Methods—Between 1992 and …

The standardized mortality ratio (SMR) for systemic lupus erythematosus (SLE) is three;
SMR increases to six in case of renal involvement. Up to now data on survival in case of …

To evaluate the long-term progression of cerebral MRI abnormalities in patients with
longstanding SLE, 30 patients (age 53.5±11.3) underwent brain MRI at baseline (b-MRI) …

Objectives To develop recommendations for the diagnosis, prevention and treatment of
neuropsychiatric systemic lupus erythematosus (NPSLE) manifestations. Methods The …

Objectives. Neuropsychiatric (NP) involvement is a poorly understood manifestation of SLE.
We studied post-mortem histopathology in relation to clinical NPSLE syndromes and …

OBJECTIVE: To apply the new American College of Rheumatology nomenclature for
neuropsychiatric systemic lupus erythematosus (NPSLE), determine the prevalence of the …